Previous 10 | Next 10 |
Danaher Corporation (DHR) Bank of America Securities Health Care Conference May 11, 2022 01:00 PM ET Company Participants Rainer Blair - CEO Conference Call Participants Derik De Bruin - Bank of America Mike Ryskin - Bank of America Presentation Derik De Bruin [Call Starts Abruptly] I’...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management. After the Q4-2021 13F filings the consensus holdings were updated, 7 stocks were removed and 7 added from the unive...
Investors bailed out of tech and growth stocks even as tech insiders added more. Insider buying on the XLK ETF has surged to the highest in the last ten years. We discuss why the bottoming in tech and growth stocks could be forming. Subsequently, we believe the outperformance in growt...
Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases PR Newswire Consortium aims to speed the development and delivery of customized or 'bespoke' gene therapies WASHINGTON , May 12, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR...
Danaher (NYSE:DHR) declares $0.25/share quarterly dividend, in line with previous. Forward yield 0.42% Payable July 29; for shareholders of record June 24; ex-div June 23. See DHR Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Danaher declares $0.25 div...
DANAHER ANNOUNCES QUARTERLY DIVIDENDS PR Newswire WASHINGTON , May 10, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.25 per share of its common sto...
Broad range RNA integrity and quality analysis kit for SCIEX capillary electrophoresis instruments launches at TIDES 2022 At TIDES 2022, SCIEX , a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches the RNA 900...
Danaher 's (NYSE: DHR) mix of life sciences and diagnostic businesses made it one of the big winners from the pandemic. Its status as one of the go-to options for investors looking for portfolio protection from a resurgence of the pandemic has never been in doubt. Its life sciences ...
Fisher's 13F portfolio value decreased from ~$179B to ~$165B in Q1 2022. Nvidia, Intuit, Broadcom, Verizon, Uber, AMD, & Meta Platforms were increased while reducing Intel, Walmart, Walt Disney, Cisco, UnitedHealth, Starbucks & Visa this quarter. The top three positions ar...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...